1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        South & Central America RNAi Therapeutics Market – By Molecule Type

1.3.2        South & Central America RNAi Therapeutics Market – By Application

1.3.3        South & Central America RNAi Therapeutics Market – By Route of Administration

1.3.4        South & Central America RNAi Therapeutics Market– By End User

1.3.5        South & Central America RNAi Therapeutics Market – By Country

2.          South & Central America RNAi Therapeutics Market –  Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          South & Central America RNAi Therapeutics Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        RNAi therapeutics Market - South & Central America PEST Analysis

4.3        Expert Opinion

5.          South & Central America RNAi Therapeutics Market -  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Growing Investments in RNAi Therapies

5.1.2        Rising Prevalence of Chronic Conditions and Infectious Diseases

5.2        Market Restraints

5.2.1        High Cost for RNAi Therapy Development

5.3        Market Opportunities

5.3.1        Significant Number of Product Approval

5.4        Future Trends

5.4.1        Rising Emphasis on RNA Technologies

5.5        Impact analysis

6.          RNAi Therapeutics Market – South & Central America Analysis

6.1        South & Central America RNAi Therapeutics Market Revenue Forecasts and Analysis

7.          South & Central America RNAi Therapeutics Market Analysis and Forecasts To 2027 – By Molecule Type

7.1        Overview

7.2        South & Central America RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

7.2.1        South & Central America RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)

7.3        Small Interfering RNAs (siRNA)

7.3.1        Overview

7.3.2        South & Central America Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)

7.4        MicroRNA (miRNA)

7.4.1        Overview

7.4.2        South & Central America MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8.          South & Central America RNAi therapeutics Market Analysis and Forecasts To 2027 – By Application

8.1        Overview

8.2        South & Central America RNAi therapeutics Market, By Application 2019 & 2027 (%)

8.2.1        South & Central America RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3        Genetic Disorders

8.3.1        Overview

8.3.2        South & Central America Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)

8.4        Oncology

8.4.1        Overview

8.4.2        South & Central America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5        Neurodegenerative Disorders

8.5.1        Overview

8.5.2        South & Central America Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.6        Cardiovascular Disorders

8.6.1        Overview

8.6.2        South & Central America Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.7        Respiratory Disorders

8.7.1        Overview

8.7.2        South & Central America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.8        Infectious Diseases

8.8.1        Overview

8.8.2        South & Central America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.9        Renal Diseases

8.9.1        Overview

8.9.2        South & Central America Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.10     Other Disorders

8.10.1     Overview

8.10.2     South & Central America Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9.          South & Central America RNAi therapeutics Market Analysis and Forecasts To 2027 – By Route of Administration

9.1        Overview

9.2        South & Central America RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

9.2.1        South & Central America RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

9.3        Intradermal Injections

9.3.1        Overview

9.3.2        South & Central America Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)

9.4        Pulmonary Delivery

9.4.1        Overview

9.4.2        South & Central America Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Intravenous Injections

9.5.1        Overview

9.5.2        South & Central America Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Intraperitoneal Injections

9.6.1        Overview

9.6.2        South & Central America Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Other Route of Administrations

9.7.1        Overview

9.7.2        South & Central America Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10.       South & Central America RNAi Therapeutics Market Analysis – By End-User

10.1     Overview

10.2     South & Central America RNAi Therapeutics Market, By End-User 2019-2027 (%)

10.2.1     South & Central America RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

10.3     Diagnostic Laboratories

10.3.1     Overview

10.3.2     South & Central America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.4     Research and Academic Laboratories

10.4.1     Overview

10.4.2     South & Central America Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.5     Hospitals

10.5.1     Overview

10.5.2     South & Central America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11.       RNAi therapeutics Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1     South & Central America: RNAi Therapeutics Market

11.1.1     Overview

11.1.2     South and Central America: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

11.1.3     South and Central America: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.4     South and Central America: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.5     South and Central America: RNAi Therapeutics Market, by Route of Administration, 2018–2027  (USD Million)

11.1.6     South and Central America: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)

11.1.7     South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

11.1.8     Brazil: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       Brazil: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       Brazil: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.8.3       Brazil: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.8.4       Brazil: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.5       Brazil: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)

11.1.9     Argentina: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Argentina: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Argentina: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.9.3       Argentina: RNAi Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.9.4       Argentina: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.5       Argentina: RNAi Therapeutics Market, by End User, 2018–2027 (USD Million)

12.       Impact of COVID-19 Pandemic on South & Central America RNAi therapeutics Market

12.1     South & Central America: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1     Alnylam Pharmaceuticals, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2     Arrowhead Pharmaceuticals, Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3     Quark

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4     Rexahn Pharmaceuticals, Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5     Arbutus Biopharma

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1     About The Insight Partners

14.2     Glossary of Terms

Table 1.            South & Central America RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)

Table 2.            South & Central America RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.            South & Central America RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 4.            South & Central America RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 5.            South and Central America RNAi Therapeutics Market, by Molecule Type– Revenue and Forecast to 2027  (USD Million)

Table 6.            South and Central America RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 7.            South and Central America RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.            South and Central America RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 9.            Brazil RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 10.         Brazil RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.         Brazil RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 12.         Brazil RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.         Argentina RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 14.         Argentina RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.         Argentina RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 16.         Argentina RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.         Glossary of Terms, RNAi Therapeutics Market

Figure 1.          RNAi Therapeutics Market Segmentation

Figure 2.          South & Central America RNAi Therapeutics Market Overview

Figure 3.          Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market

Figure 4.          Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          South & Central America RNAi Therapeutics Market - Leading Country Markets (US$ Mn)

Figure 6.          RNAi Therapeutics Market - South & Central America PEST Analysis

Figure 7.          RNAi Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.          South & Central America RNAi Therapeutics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          South & Central America RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

Figure 10.        South & Central America Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        South & Central America MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        South & Central America RNAi therapeutics Market, By Application 2019 & 2027 (%)

Figure 13.        South & Central America Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        South & Central America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        South & Central America Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        South & Central America Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        South & Central America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        South & Central America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        South & Central America Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        South & Central America Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        South & Central America RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

Figure 22.        South & Central America Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        South & Central America Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        South & Central America Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        South & Central America Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        South & Central America Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        South & Central America RNAi Therapeutics Market, by End-User 2019 & 2027 (%)

Figure 28.        South & Central America Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        South & Central America Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        South & Central America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.        South and Central America: RNAi Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 32.        South and Central America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 33.        South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

Figure 34.        Brazil: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Argentina: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic in South & Central American Country Markets